AFCM
Applied Finance Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
30,928
+2,708
| +10% | +$1.1M | 0.86% | 46 |
|
|
2025
Q1 | $14M | Sell |
28,220
-22,549
| -44% | -$11.2M | 1.03% | 40 |
|
|
2024
Q4 | $26.4M | Sell |
50,769
-1,744
| -3% | -$907K | 1.15% | 40 |
|
|
2024
Q3 | $32.5M | Buy |
52,513
+665
| +1% | +$411K | 1.39% | 31 |
|
|
2024
Q2 | $28.7M | Buy |
51,848
+16,165
| +45% | +$8.94M | 1.33% | 38 |
|
|
2024
Q1 | $20.7M | Buy |
35,683
+4,117
| +13% | +$2.39M | 1.46% | 41 |
|
|
2023
Q4 | $16.8M | Buy |
31,566
+3,297
| +12% | +$1.75M | 1.46% | 40 |
|
|
2023
Q3 | $14.3M | Buy |
28,269
+2,196
| +8% | +$1.11M | 1.56% | 39 |
|
|
2023
Q2 | $13.6M | Buy |
26,073
+887
| +4% | +$463K | 1.54% | 37 |
|
|
2023
Q1 | $14.5M | Buy |
25,186
+304
| +1% | +$175K | 1.81% | 27 |
|
|
2022
Q4 | $13.7M | Buy |
+24,882
| New | +$13.7M | 1.79% | 28 |
|